Concentriq AP-Dx

Diagnostic digital pathology platform for slide management, case review, and workflow integration.

License: proprietary
Open source: No

Editorial review

Concentriq AP-Dx has not yet been editorially reviewed. User reviews and published field data below are unaffected — we say so rather than implying an editorial verdict.

Facts & attributes

Every value carries its evidence state. “—” means unknown — never a silent default (P-02).

Identity · Taxonomy

Tags(open-source;cloud-native): digital-pathology, ai, computational-pathology, diagnostics, life-sciencesVerification pending

Pricing · Licensing

License model(proprietary;open-source;source-available;dual-license): proprietaryVerification pending

Features · Product · Fit

Core capabilities(authoring;automation;analytics): Viewing, managing, reviewing and interpreting digital images of scanned surgical pathology slides, Pathology primary diagnosis support for FFPE tissue specimens, AI applications for biomarker research and companion diagnostics, Clinical trial and study image analysis at scaleVerification pending

Security · Privacy · Compliance

Regulatory compliance(HIPAA;PCI DSS;FedRAMP;GDPR support): FDA-cleared, Health Canada licensed, CE-marked under the EU IVDRVerification pending

Audience · Use · Case

Best for(Neutral editorial summary): Hospital labs and biopharma running FDA-cleared AI-enabled digital pathology for primary diagnosis and biomarker research.Verification pending
Company-size fit(individual;SMB;mid-market;enterprise): mid-market, enterpriseVerification pending
Primary use cases(build;monitor;automate): Pathology primary diagnosis in clinical labs, Biomarker discovery and validation, Companion diagnostics development, Clinical trial image analysisVerification pending
Skill level(beginner;intermediate;advanced;specialist): specialistVerification pending

Lifecycle · Versioning

Maintenance status(active;maintenance;deprecated;EOL;archived): activeVerified

Vendor · Maintainer

Vendor type(commercial;foundation;community;government;consortium;individual): commercialVerification pending

User reviews

Review policy

No published reviews yet.